Southeast Asset Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.4M | Buy |
99,468
+944
| +1% | +$24.7K | 0.24% | 63 |
|
|
2026
Q1 | $2.77M | Buy |
98,524
+4,901
| +5% | +$130K | 0.3% | 51 |
|
|
2025
Q4 | $2.33M | Buy |
93,623
+17,723
| +23% | +$447K | 0.22% | 73 |
|
|
2025
Q3 | $1.93M | Buy |
75,900
+26,352
| +53% | +$650K | 0.21% | 72 |
|
|
2025
Q2 | $1.2M | Sell |
49,548
-1,107
| -2% | -$25.8K | 0.14% | 88 |
|
|
2025
Q1 | $1.28M | Buy |
50,655
+5,909
| +13% | +$155K | 0.16% | 82 |
|
|
2024
Q4 | $1.19M | Sell |
44,746
-2,035
| -4% | -$55.2K | 0.15% | 80 |
|
|
2024
Q3 | $1.35M | Sell |
46,781
-610
| -1% | -$17.8K | 0.15% | 74 |
|
|
2024
Q2 | $1.33M | Buy |
47,391
+581
| +1% | +$16K | 0.16% | 74 |
|
|
2024
Q1 | $1.3M | Sell |
46,810
-3,951
| -8% | -$110K | 0.16% | 75 |
|
|
2023
Q4 | $1.46M | Sell |
50,761
-1,355
| -3% | -$41K | 0.19% | 68 |
|
|
2023
Q3 | $1.73M | Buy |
52,116
+3,435
| +7% | +$121K | 0.24% | 55 |
|
|
2023
Q2 | $1.79M | Buy |
48,681
+81
| +0.2% | +$3.15K | 0.25% | 52 |
|
|
2023
Q1 | $1.98M | Sell |
48,600
-2,336
| -5% | -$101K | 0.3% | 47 |
|
|
2022
Q4 | $2.61M | Sell |
50,936
-1,191
| -2% | -$57.1K | 0.41% | 40 |
|
|
2022
Q3 | $2.28M | Sell |
52,127
-3,329
| -6% | -$162K | 0.39% | 41 |
|
|
2022
Q2 | $2.91M | Sell |
55,456
-214
| -0.4% | -$10.9K | 0.46% | 33 |
|
|
2022
Q1 | $2.88M | Buy |
55,670
+62
| +0.1% | +$3.22K | 0.38% | 39 |
|
|
2021
Q4 | $3.28M | Buy |
55,608
+509
| +0.9% | +$25.2K | 0.45% | 40 |
|
|
2021
Q3 | $2.37M | Buy |
55,099
+3,791
| +7% | +$168K | 0.39% | 51 |
|
|
2021
Q2 | $2.01M | Buy |
51,308
+13,016
| +34% | +$506K | 0.33% | 54 |
|
|
2021
Q1 | $1.39M | Buy |
38,292
+1,278
| +3% | +$45.4K | 0.25% | 62 |
|
|
2020
Q4 | $1.36M | Sell |
37,014
-1,923
| -5% | -$70.5K | 0.27% | 59 |
|
|
2020
Q3 | $1.36M | Sell |
38,937
-40
| -0.1% | -$1.4K | 0.3% | 51 |
|
|
2020
Q2 | $1.21M | Buy |
38,977
+1,866
| +5% | +$63.4K | 0.3% | 51 |
|
|
2020
Q1 | $1.15M | Buy |
37,111
+109
| +0.3% | +$3.71K | 0.34% | 47 |
|
|
2019
Q4 | $1.38M | Sell |
37,002
-282
| -0.8% | -$10K | 0.33% | 49 |
|
|
2019
Q3 | $1.27M | Sell |
37,284
-1,868
| -5% | -$67.9K | 0.32% | 48 |
|
|
2019
Q2 | $1.61M | Buy |
39,152
+728
| +2% | +$28.9K | 0.42% | 41 |
|
|
2019
Q1 | $1.55M | Buy |
38,424
+59
| +0.2% | +$2.36K | 0.41% | 39 |
|
|
2018
Q4 | $1.59M | Sell |
38,365
-1,140
| -3% | -$47.3K | 0.48% | 34 |
|
|
2018
Q3 | $1.65M | Buy |
39,505
+51
| +0.1% | +$1.96K | 0.44% | 34 |
|
|
2018
Q2 | $1.36M | Sell |
39,454
-259
| -0.7% | -$8.85K | 0.39% | 37 |
|
|
2018
Q1 | $1.34M | Buy |
39,713
+57
| +0.1% | +$1.96K | 0.4% | 38 |
|
|
2017
Q4 | $1.36M | Buy |
39,656
+353
| +0.9% | +$12K | 0.41% | 37 |
|
|
2017
Q3 | $1.33M | Sell |
39,303
-3,110
| -7% | -$100K | 0.42% | 31 |
|
|
2017
Q2 | $1.35M | Buy |
42,413
+1,537
| +4% | +$48.5K | 0.44% | 32 |
|
|
2017
Q1 | $1.33M | Buy |
40,876
+1,110
| +3% | +$35K | 0.41% | 31 |
|
|
2016
Q4 | $1.23M | Sell |
39,766
-2,083
| -5% | -$63.6K | 0.39% | 35 |
|
|
2016
Q3 | $1.34M | Buy |
41,849
+513
| +1% | +$17.2K | 0.45% | 31 |
|
|
2016
Q2 | $1.38M | Sell |
41,336
-961
| -2% | -$30.7K | 0.45% | 26 |
|
|
2016
Q1 | $1.19M | Hold |
42,297
| – | – | 0.39% | 34 |
|
|
2015
Q4 | $1.29M | Buy |
42,297
+17,620
| +71% | +$554K | 0.44% | 29 |
|
|
2015
Q3 | $735K | Buy |
24,677
+1
| +0% | +$32 | 0.28% | 43 |
|
|
2015
Q2 | $785K | Hold |
24,676
| – | – | 0.28% | 46 |
|
|
2015
Q1 | $815K | Hold |
24,676
| – | – | 0.28% | 45 |
|
|
2014
Q4 | $729K | Buy |
24,676
+1
| +0% | +$29 | 0.26% | 48 |
|
|
2014
Q3 | $692K | Hold |
24,675
| – | – | 0.26% | 49 |
|
|
2014
Q2 | $695K | Buy |
24,675
+212
| +0.9% | +$6.04K | 0.26% | 50 |
|
|
2014
Q1 | $746K | Buy |
24,463
+1,707
| +8% | +$50.9K | 0.29% | 48 |
|
|
2013
Q4 | $661K | Sell |
22,756
-526
| -2% | -$15.3K | 0.26% | 55 |
|
|
2013
Q3 | $635K | Sell |
23,282
-1,370
| -6% | -$37.3K | 0.28% | 55 |
|
|
2013
Q2 | $655K | Buy |
+24,652
| New | +$681K | 0.3% | 50 |
|
Other funds holding PFE
Southeast Asset Advisors's PFE Position: Q2 2026 in Review
Southeast Asset Advisors increased its Pfizer (PFE) stake by 0.96% in Q2 2026, buying an estimated $24.7K and bringing the position to 99,468 shares worth $2.4M. The position accounts for 0.24% of the portfolio, ranked #63.
Southeast Asset Advisors first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.28M in Q4 2021. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Southeast Asset Advisors held 99,468 shares of Pfizer worth $2.4M as of Q2 2026.
- Southeast Asset Advisors bought 944 Pfizer shares in Q2 2026, an estimated $24.7K.
- Pfizer made up 0.24% of Southeast Asset Advisors's portfolio in Q2 2026, its #63 holding.
- Southeast Asset Advisors first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Southeast Asset Advisors's Pfizer position peaked at $3.28M in Q4 2021.
- 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Southeast Asset Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.